Kir1.1 and SUR1 are not implicated as subunits of an adenosine triphosphate-sensitive potassium channel involved in diazoxide cardioprotectionCentral MessagePerspective by Jie Wang, MD, Kyriakos Papanicolaou, PhD, Robert Tryon, PhD, Janelle Sangalang, BA, Ben Salazar, BS, Alejandro Suarez-Pierre, MD, Jie Dong, MD, Anson Lee, BS, BA, Emily Larson, BS, Sari Holmes, PhD, Brian O’Rourke, PhD, Colin Nichols, PhD, Jennifer Lawton, MD

Get full text

Commentary: One artery does not fit all: Tailoring the operation to the patientCentral Message by Jennifer S. Lawton, MD

Get full text

Sex and Gender Differences in Coronary Artery Disease by Lawton, Jennifer S., MD

Get full text

Cardioprotective mechanisms of mitochondria-targeted S-nitrosating agent and adenosine triphosphate-sensitive potassium channel opener are mutually exclusiveCentral MessagePerspect... by Thaniyyah Ahmad, MD, Jie Wang, MD, Ana Karen Velez, MD, Alejandro Suarez-Pierre, MD, Kathleen C. Clement, MD, Jie Dong, Krisztian Sebestyen, MS, Joseph K. Canner, MHS, Michael P. Murphy, PhD, Jennifer S. Lawton, MD

Get full text

Increased Tolerance to Stress in Cardiac Expressed Gain-of-Function of KATP Channel Subunit Kir6.1 by Henn, Matthew C., MD, Janjua, M. Burhan, MD, Zhang, Haixia, PhD, Kanter, Evelyn M., BS, Makepeace, Carol M., BS, Schuessler, Richard B., PhD, Nichols, Colin G., PhD, Lawton, Jennifer S., MD, FACS

Get full text

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial by Banerjee, Sube, Prof, Hellier, Jennifer, MSc, Dewey, Michael, PhD, Romeo, Renee, PhD, Ballard, Clive, MD, Baldwin, Robert, MD, Bentham, Peter, MRCPsych, Fox, Chris, MD, Holmes, Clive, PhD, Katona, Cornelius, MD, Knapp, Martin, PhD, Lawton, Claire, FRCPsych, Lindesay, James, DM, Livingston, Gill, MD, McCrae, Niall, PhD, Moniz-Cook, Esme, PhD, Murray, Joanna, MA, Nurock, Shirley, MSc, Orrell, Martin, PhD, O'Brien, John, DM, Poppe, Michaela, PhD, Thomas, Alan, PhD, Walwyn, Rebecca, PhD, Wilson, Kenneth, MD, Burns, Alistair, MD

Get full text

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities by Xiao, Canhua, PhD, Moughan, Jennifer, MS, Movsas, Benjamin, MD, Konski, Andre A., MD, Hanks, Gerald E., MD, Cox, James D., MD, Roach, Mack, MD, Zeitzer, Kenneth L., MD, Lawton, Colleen A., MD, Peters, Christopher A., MD, Rosenthal, Seth A., MD, Hsu, I.-Chow Joe, MD, Horwitz, Eric M., MD, Mishra, Mark V., MD, Michalski, Jeff M., MD, Parliament, Matthew B., MD, D'Souza, David P., MD, Pugh, Stephanie L., PhD, Bruner, Deborah W., PhD

Get full text

Baseline differences in the HF-ACTION trial by sex by Piña, Ileana L., MD, Kokkinos, Peter, PhD, Kao, Andrew, MD, Bittner, Vera, MD, Saval, Matt, MS, Clare, Bob, MS, Goldberg, Lee, MD, Johnson, Maryl, MD, Swank, Ann, PhD, Ventura, Hector, MD, Moe, Gordon, MD, Fitz-Gerald, Meredith, RN, Ellis, Stephen J., PhD, Vest, Marianne, MS, RN, Cooper, Lawton, MD, MHS, Whellan, David, MD, MHS

Get full text